Asset profile
PAS-004 · Pasithea Therapeutics Corp. (KTTA)
- Indication
- Amyotrophic Lateral Sclerosis (ALS)
- Also known as
- PAS-004
Company
KTTAPasithea Therapeutics Corp.
KTTAPasithea Therapeutics Corp.Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields…
On the calendar
Nothing scheduled in this window.
Timeline
Newest first.
Jun 2, 2026
11:02 AM
KTTAPasithea Therapeutics Corp.Pasithea receives FDA Orphan Drug Designation for PAS-004 in ALS